Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement C1s is a serine protease and a key component of the classical pathway of the complement system. Upon activation, it cleaves complement components C4 and C2, leading to downstream immune responses. Dysregulation or deficiency can lead to increased susceptibility to infections or autoimmune diseases. Elevated levels/activity have been associated with certain pathologies, making it a potential therapeutic target.
Serine protease inhibitor (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement C1s Protein (C1s).